Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.
BACKGROUND
The European Community has made a commitment to colorectal cancer (CRC) screening, but regional considerations may affect the design of national screening programs. We developed a decision analytic model tailored to a pilot screening program for high-risk persons in Spain with the aim of informing public policy decisions.


METHODS
We constructed a decision analytic Markov model based on our validated model of CRC screening that reflected CRC epidemiology and costs in persons with first-degree relatives with CRC in Aragón, Spain, and superimposed colonoscopy every 5 or 10 years from ages 40 to 80 years. The pilot program's preliminary clinical results and our modeling results were presented to regional health authorities.


RESULTS
In the model, without screening, 88 CRC cases occurred per 1,000 persons from age 40 to 85 years. In the base case, screening reduced this by 72% to 77% and gained 0.12 discounted life years per person. Screening every 10 years was cost saving, and screening every 5 years versus every 10 years cost 7,250 euros per life year gained. Based on these savings, 36 to 39 euros per person per year could go toward operating costs while maintaining a neutral budget. If screening costs doubled, screening remained highly cost-effective but no longer cost saving. These results contributed to the health authorities' decision to expand the pilot program to the entire region in 2009.


CONCLUSIONS
Colonoscopic screening of first-degree relatives of persons with CRC may be cost saving in public systems like that of Spain. Decision analytic modeling tailored to regional considerations can inform public policy decisions.


CONCLUSIONS
Tailored decision analytic modeling can inform regional policy decisions on cancer screening.
Ladabaum
Uri
U
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, CA 94063, USA. uri.ladabaum@stanford.edu
Ferrandez
Angel
A
Lanas
Angel
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003113:Colonoscopy / Q000191:economics*; D015179:Colorectal Neoplasms / Q000191:economics* / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D055088:Early Detection of Cancer / Q000191:economics* / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008390:Markov Chains; D008403:Mass Screening / Q000191:economics* / Q000379:methods; D008875:Middle Aged; D011640:Public Policy; D013030:Spain
Gastroenterology. 2008 May;134(5):1570-95
18384785
Ann Intern Med. 2001 Nov 6;135(9):769-81
11694102
J Clin Oncol. 2004 Apr 1;22(7):1201-8
14993230
J Natl Cancer Inst. 2000 Apr 5;92(7):557-63
10749911
Gastroenterology. 2000 Sep;119(3):837-53
10982778
Gastroenterology. 2002 Dec;123(6):1786-92
12454834
Ann Intern Med. 2006 Dec 19;145(12):880-6
17179057
N Engl J Med. 1993 May 13;328(19):1365-71
8474513
Am J Med. 2003 May;114(7):546-54
12753878
Gastrointest Endosc. 1991 Mar-Apr;37(2):125-7
2032595
Int J Technol Assess Health Care. 2010 Jan;26(1):40-7
20059779
Eur J Cancer. 2006 Jan;42(2):216-27
16338133
N Engl J Med. 2000 Jul 20;343(3):162-8
10900274
Gastroenterology. 1997 Feb;112(2):594-642
9024315
Am J Gastroenterol. 2010 Aug;105(8):1861-9
20461066
Neth J Med. 2006 Nov;64(10):367-70
17122453
Gastroenterology. 2006 May;130(6):1872-85
16697750
Cancer. 1979 May;43(5):1847-57
445371
J Clin Oncol. 2004 Jan 1;22(1):23-30
14665611
N Engl J Med. 2004 Jun 3;350(23):2335-42
15175435
Am J Med. 2001 Dec 1;111(8):593-601
11755501
Dis Colon Rectum. 1964 Jul-Aug;7:249-61
14176135
Clin Gastroenterol Hepatol. 2004 Jul;2(7):554-63
15224279
Aliment Pharmacol Ther. 2008 Apr;27(8):697-712
18248653
Clin Gastroenterol Hepatol. 2008 Nov;6(11):1231-6
18995214
N Engl J Med. 2006 Nov 2;355(18):1863-72
17079760
Aliment Pharmacol Ther. 2003 Nov;18 Suppl 3:7-30
14531737
Gastroenterology. 1997 Jan;112(1):17-23
8978337
JAMA. 2000 Oct 18;284(15):1954-61
11035892
Ann Intern Med. 2000 Oct 17;133(8):573-84
11033584
Gastroenterology. 1997 Jan;112(1):24-8
8978338
Gastroenterology. 1995 Dec;109(6):1781-90
7498642
Int J Cancer. 1985 Aug 15;36(2):179-86
4018911
N Engl J Med. 1992 Mar 5;326(10):653-7
1736103
Clin Gastroenterol Hepatol. 2006 Jul;4(7):808-21
16797250
N Engl J Med. 2005 Feb 3;352(5):476-87
15689586
Int J Cancer. 2009 Mar 1;124(5):1161-8
19048626
Gastroenterology. 2010 Mar;138(3):877-85
19932107
Gut. 1982 Oct;23(10):835-42
7117903
Endoscopy. 2007 Feb;39(2):168-73
17327977
N Engl J Med. 2000 Nov 30;343(22):1603-7
11096167
J Natl Cancer Inst. 2010 Jan 20;102(2):89-95
20042716
Ann Intern Med. 2008 Nov 4;149(9):659-69
18838717
Radiology. 2001 Jun;219(3):685-92
11376255
Gastroenterology. 2005 Oct;129(4):1151-62
16230069
Gastroenterology. 1987 Mar;92(3):682-92
3102307
Gastroenterology. 2004 May;126(5):1270-9
15131787
Cancer. 1982 Feb 15;49(4):819-25
7055790
Ann Intern Med. 2002 Jul 16;137(2):96-104
12118964
J Clin Oncol. 2003 Jan 1;21(1):60-5
12506171
Int J Technol Assess Health Care. 2000 Summer;16(3):799-810
11028135
Surg Endosc. 1994 Jun;8(6):672-6
8059305
N Engl J Med. 2004 Jul 22;351(4):337-45
15269313
Ann Intern Med. 2009 Jan 6;150(1):1-8
19075198
Gut. 1997 Jul;41(1):8-13
9274464
Genet Med. 2006 Sep;8(9):571-5
16980813
Eur J Cancer. 2009 Apr;45(6):931-91
19171476
Gastroenterol Hepatol. 2009 Dec;32(10):717.e1-58
20474100
Lancet Oncol. 2007 Sep;8(9):773-83
17714991